Explore
Validate
LearnABIN952158
antibody from antibodies-online
Targeting: FADS2
D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952158 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fatty Acid Desaturase 2 (FADS2) (AA 78-108), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A Chromatoghraphy followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 78-108, N-Term
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references FADS genetic variants and omega-6 polyunsaturated fatty acid metabolism in a homogeneous island population.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Mathias RA, Vergara C, Gao L, Rafaels N, Hand T, Campbell M, Bickel C, Ivester P, Sergeant S, Barnes KC, Chilton FH
Journal of lipid research 2010 Sep;51(9):2766-74
Journal of lipid research 2010 Sep;51(9):2766-74
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
